IL-2 Receptor Antagonist (Basiliximab) Is Associated with Rapid Fibrosis Progression in Patients with Recurrent Hepatitis C after Liver Transplantation

IL-2 Receptor Antagonist (Basiliximab) Is Associated with Rapid Fibrosis Progression in Patients with Recurrent Hepatitis C after Liver Transplantation

Background: Recurrence of hepatitis C virus (HCV) infection following orthotopic liver transplantation (OLT) is universal. There is paucity of data on the safety and efficacy of interleukin (IL)-2 receptor antagonist (IL-2RA) when added to the standard immunosuppression regimen in OLT recipients wit...

Full description

Bibliographic Details
Main Authors: Ibrahim A. Hanouneh, Nizar N. Zein, Rocio Lopez, Lisa Yerian, John Fung, Bijan Eghtesad
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2010-01-01
Series:International Journal of Organ Transplantation Medicine
Subjects:
Transplantation
liver
interleukin receptor antagonist
hepatitis C virus
liver fibrosis
cirrhosis
Online Access:http://home.sums.ac.ir/~habibzaf/ojs/index.php/IJOTM/article/view/3/17

Internet

http://home.sums.ac.ir/~habibzaf/ojs/index.php/IJOTM/article/view/3/17

Similar Items